Hansa Biopharma AB (HNSBF)
Hansa Biopharma Market Cap : 289.23M for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BONESUPPORT HOLDING AB | 1.656B |
| BioInvent International AB | 216.40M |
| BioArctic AB | 3.075B |
| Swedish Orphan Biovitrum AB | 16.19B |
| Egetis Therapeutics AB | 293.40M |
Market Cap Related Metrics
| PS Ratio | 12.90 |
| Price | 2.90 |
| Earnings Yield | -28.58% |